{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-13",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Ineligible",
      "product_code": "QSE",
      "openfda": {
        "k_number": [
          "DEN200072",
          "K231348",
          "K221842"
        ],
        "registration_number": [
          "2521625",
          "9610126",
          "2032839",
          "3002895169"
        ],
        "fei_number": [
          "3002806559",
          "3004185580",
          "2521625",
          "3002895169"
        ]
      },
      "review_panel": "IM",
      "medical_specialty": "IM",
      "device_name": "Alzheimer’S Disease Pathology Assessment Test",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Immunology",
      "device_class": "2",
      "definition": "In vitro test to determine whether a patient presenting with cognitive impairment and being evaluated for AD and other causes of cognitive decline will test positive or negative for amyloid plaques or neurofibrillary tangles as measured by PET imaging agents.",
      "regulation_number": "866.5840",
      "implant_flag": "N",
      "submission_type_id": "1"
    }
  ]
}